Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ai-Lin Zhong"'
Autor:
Qian Zhu, Ai-Lin Zhong, Hao Hu, Jing-Jing Zhao, De-Sheng Weng, Yan Tang, Qiu-Zhong Pan, Zi-Qi Zhou, Meng-Jia Song, Jie-Ying Yang, Jun-Yi He, Yuan Liu, Min Li, Wan-Ming Hu, Chao-Pin Yang, Tong Xiang, Ming-Yuan Chen, Gang Ma, Ling Guo, Jian-Chuan Xia
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/ba71c9b1b1fe4145b05022e7b1aa3434
Autor:
Qian Zhu, Ai-Lin Zhong, Hao Hu, Jing-Jing Zhao, De-Sheng Weng, Yan Tang, Qiu-Zhong Pan, Zi-Qi Zhou, Meng-Jia Song, Jie-Ying Yang, Jun-Yi He, Yuan Liu, Min Li, Wan-Ming Hu, Chao-Pin Yang, Tong Xiang, Ming-Yuan Chen, Gang Ma, Ling Guo, Jian-Chuan Xia
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-16 (2020)
Abstract Background Clinically, the median survival in patients with metastatic renal cell carcinoma (RCC) was only 6–12 months and a 5-year survival rate of less than 20%. Therefore, an in-depth study of the molecular mechanisms involved in RCC is
Externí odkaz:
https://doaj.org/article/adf556a0a1964c06ad93d70cfbcfc683
Autor:
De-Sheng Weng, J. Yang, Xiao-Cong Mo, Qian Zhu, Yuan Liu, Jian Chuan Xia, Mengjia Song, Yue Huang, Hao Chen, Jing Jing Zhao, Yan Tang, Zi-Qi Zhou, Shaoyan Cheng, Chaopin Yang, Qiu-Zhong Pan, Junyi He, Ai-Lin Zhong, Jianxiong Zeng
Publikováno v:
Aging (Albany NY)
The abnormal expression of noncoding RNAs has attracted increasing interest in the field of hepatocellular carcinoma progression. However, the underlying molecular mechanisms mediated by noncoding RNAs in these processes are unclear. Here, we obtaine
Autor:
Wan Ming Hu, Ling Guo, Yan Tang, Jing Jing Zhao, Ai Lin Zhong, Meng Jia Song, Jian Chuan Xia, Qiu Zhong Pan, Gang Ma, Ming Yuan Chen, Chao Pin Yang, Tong Xiang, Yuan Liu, De Sheng Weng, Min Li, Qian Zhu, Hao Hu, Jie Ying Yang, Jun Yi He, Zi Qi Zhou
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-16 (2020)
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-16 (2020)
Background Clinically, the median survival in patients with metastatic renal cell carcinoma (RCC) was only 6–12 months and a 5-year survival rate of less than 20%. Therefore, an in-depth study of the molecular mechanisms involved in RCC is of great
Autor:
Yan Tang, Jian-Chuan Xia, Ai-Lin Zhong, Wan-Ming Hu, Min Li, Ming-Yuan Chen, De-Sheng Weng, Hao Hu, Gang Ma, Qiu-Zhong Pan, Qian Zhu, Jing Jing Zhao
Publikováno v:
International Immunopharmacology. 89:107139
Accumulating evidence has indicated that inflammation is required for the initiation and progression of hepatocellular carcinoma (HCC). The annexin family protein, which has a highly similar structure, has been demonstrated to participate in pro- or